发明名称 CATIONIC THERAPEUTIC SYSTEMS
摘要 PROBLEM TO BE SOLVED: To reduce an unpleasant feeling accompanying the use of a therapeutic agent at the time of treating glaucoma, and the like by providing the surface of mucosa with an aqueous solution containing a specific cationic polysaccharide polymer and a cationic therapeutic agent continuously releasing a therapeutic agent. SOLUTION: The surface of mucosa is provided with a solution comprising (A) water, (B) a cationic polysaccharide in an effective amount to provide the surface of mucosa with sustantivity and to produce a clear solution, replaced with >=0.1 moles per mole of polysaccharide of a quaternary nitrogen compound containing a 1-4C hydrocarbon substituent group per substituent group based on 1mol of the polysaccharide and (C) an effective amount of a cationic therapeutic agent to reach the surface of mucosa and to maintain a clear solution. A cationic cellulose compound substituted with 2,3- epoxypropyltrimethylammonium chloride is preferable as the composition B. For example, aβ-blocker such as betaxolol and a therapeutic agent for glaucoma such as epinephrine may be cited as the component C.
申请公布号 JPH10182498(A) 申请公布日期 1998.07.07
申请号 JP19960359632 申请日期 1996.12.20
申请人 UNION CARBIDE CHEM & PLAST TECHNOL CORP 发明人 DONABEDIAN DAVID H;MARLIN LAWRENCE;ING DONA J
分类号 A61K9/08;A61K47/30;A61K47/38;A61P27/02;A61P27/06;(IPC1-7):A61K47/38 主分类号 A61K9/08
代理机构 代理人
主权项
地址